Dr. Sara Brenner, who has been FDA CDRH's in vitro diagnostics chief medical officer, is serving as acting commissioner of ...
Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...
Beta CEO Marcel Botha talks about the FDA’s plans for medical shortage notifications and how Trump’s policies may impact US ...
The website changes raise concerns about “the interference of politics with the study and the practice” of science and ...
The FDA is urging Congress to implement mandatory medical device shortage reporting to address growing vulnerabilities in the ...
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has launched a national search for a new Director for the Center ...
The FDA is particularly concerned that supply chain issues are having an adverse impact on neonatal and paediatric patients.
AI is touching every industry, and healthcare is no exception: the global market size for healthcare AI, which was valued at ...
While medical device shortages are nothing new, the FDA said it is becoming more concerned that supply chain disruptions are ...
The FDA has tapped Sara Brenner to serve as acting commissioner as it awaits new leadership from the Trump administration to ...
What is the Voluntary Improvement Program? The Case for Quality collaborative community Voluntary Improvement Program (VIP) was developed with FDA CDRH, MDIC, ISACA and the medical device industry.